DeepCell
Where AI meets living cells
- Headquarters
- San Francisco Bay Area, California
- Employees
- 51–200
- Founded
- 2017
- Business Model
- B2B
- Website
- deepcell.com
- Total Funding
- $20.0M
- Last Round
- $20.0M Series ADec 2020
- Rounds
- 1
About
DeepCell is a life sciences technology company that has developed the REM-I platform — an integrated system combining label-free imaging, deep learning AI, and gentle cell enrichment to analyze and sort living cells based on their morphology. The platform enables researchers and clinicians to profile single cells without fluorescent labels or destructive preparation, revealing high-dimensional biological insights invisible to conventional methods. Key application areas include oncology (tumor heterogeneity, rare cell sorting), drug discovery (phenotypic screening, mechanism of action), and cell and gene therapy (quality control, manufacturing). DeepCell is headquartered in Menlo Park, California.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Dec 2020
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company
Specialty pharmaceutical company

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...